Angiotensin converting enzyme inhibitors: structure-activity profile of 1-benzazepin-2-one derivatives

Citations Over TimeTop 21% of 1985 papers

Abstract

The preparation of a series of 3-amino-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepine-1-acetic acid derivatives 5a-y by reductive amination of 2,3,4,5-tetrahydro-1H-1-benzazepine-2,3-dione (7) with L-amino acid derivatives is described. The compounds were tested for inhibition of angiotensin converting enzyme. The structure-activity profile of the series is discussed. Compound 5a was especially potent when tested in dogs for inhibition of angiotensin I pressor response, having an ID50 = 0.07 mg/kg po.

Related Papers

• → Central and Peripheral Inhibition of Angiotensin Converting Enzyme (ACE) in the Shr: Correlation with the Antihypertensive Activity of ACE Inhibitors(1987)26 cited
• → Renin inhibitors, angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists(1992)15 cited
• Initial evaluation of the non-sulfhydryl-containing converting enzyme inhibitor MK-521 in hypertensive humans.(1984)
• → Angiotensin I‐converting enzyme (ACE) inhibition and antihypertensive effects of EU‐5476, a new, potent, and long‐acting ACE inhibitor(1986)2 cited
• [Synthesis of angiotensin converting enzyme inhibitor, captopril ester derivatives].(1988)